TPTX - Turning Point Therapeutics Inc. (TPTX) CEO Athena Countouriotis on Q1 2020 Results - Earnings Call Transcript
Turning Point Therapeutics, Inc. (TPTX)
Q1 2020 Earnings Conference Call
May 12, 2020 4:30 p.m. ET
Company Participants
Jim Mazzola - SVP, Communication and IR
Athena Countouriotis - President and CEO
Yi Larson - EVP and CFO
Conference Call Participants
Corinne Jenkins - Goldman Sachs
Jim Birchenough - Wells Fargo
Michael Schmidt - Guggenheim Partners
Robert Burns - H.C. Wainwright
Zegbeh Jallah - ROTH Capital Partners
Arlinda Lee - Canaccord Genuity
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Turning Point Therapeutics' First Quarter 2020 Conference Call. At this